ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 106,786 | 94,232 | 83,821 | 73,855 | 64,477 |
| Cost of Goods | 37,708 | 36,326 | 32,894 | 35,294 | 34,271 |
| Gross Profit | 69,078 | 57,906 | 50,927 | 38,561 | 30,206 |
| Operating Expenses | 59,891 | 56,412 | 56,816 | 51,768 | 49,672 |
| Operating Income | 9,895 | 1,820 | -4,995 | -12,913 | -19,195 |
| Interest Expense | 7,696 | 7,506 | 7,264 | 6,669 | 6,613 |
| Other Income | -34 | -42 | 37 | 764 | -89 |
| Pre-tax Income | 2,165 | -5,728 | -12,222 | -18,818 | -25,897 |
| Income Tax | 726 | -1,485 | -3,622 | -3,895 | -5,767 |
| Net Income Continuous | 1,439 | -4,243 | -8,600 | -14,923 | -20,130 |
| Net Income | $1,439 | $-4,243 | $-8,600 | $-14,923 | $-20,130 |
| EPS Basic Total Ops | 0.06 | -0.29 | -0.55 | -0.94 | -1.27 |
| EPS Basic Continuous Ops | 0.09 | -0.25 | -0.53 | -0.92 | -1.25 |
| EPS Diluted Total Ops | 0.06 | -0.29 | -0.55 | -0.94 | -1.27 |
| EPS Diluted Continuous Ops | 0.09 | -0.25 | -0.53 | -0.92 | -1.25 |
| EBITDA(a) | $24,595 | $17,392 | $10,355 | $1,261 | $-4,638 |